» Articles » PMID: 25660979

Detection of Peritoneal Carcinomatosis by EUS Fine-needle Aspiration: Impact on Staging and Resectability (with Videos)

Abstract

Background: Peritoneal carcinomatosis (PC) greatly affects cancer staging and resectability.

Objective: To compare the PC detection rate by using EUS and noninvasive imaging and to determine the impact on staging and resectability.

Design: Retrospective study.

Setting: Single tertiary-care referral center.

Patients: A prospectively maintained EUS database was reviewed to identify patients who underwent EUS-guided FNA (EUS-FNA) of a peritoneal anomaly. Findings were compared with a strict criterion standard that incorporated cytohistologic, radiologic, and clinical data.

Intervention: EUS-FNA of a peritoneal anomaly.

Main Outcome Measurements: Safety and diagnostic yield.

Results: Of 106 patients, a criterion standard was available in 98 (39 female patients; median age, 65 years). The sensitivity, specificity, and accuracy of EUS-FNA versus CT/magnetic resonance imaging (MRI) was 91% versus 28%, 100% versus 85%, and 94% versus 47%, respectively. In newly diagnosed cancer patients, peritoneal FNA upstaged 17 patients (23.6%). Of 32 patients deemed resectable by pre-EUS CT/MRI, 15 (46.9%) were deemed unresectable based solely on peritoneal FNA. The odds of FNA changing the resectability status remained highly significant after adjustment for cancer type, time between CT/MRI and EUS-FNA, and the quality of CT/MRI. The malignant appearance of the peritoneal anomaly but not the presence of ascites on EUS predicted a positive FNA finding (odds ratio 2.56; 95% confidence interval, 1.23-5.4 and odds ratio 0.83; 95% confidence interval, 0.4-1.8, respectively). There were 3 adverse events among 4 patients. Two of the patients developed abdominal pain and one each hypertensive urgency and pancreatitis.

Limitations: Retrospective design, single-center, bias toward EUS as a diagnostic test.

Conclusion: Peritoneal EUS-FNA appears to safely detect radiographically occult PC and improve cancer staging and patient care.

Citing Articles

Current perspectives on the diversification of endoscopic ultrasound-guided fine-needle aspiration and biopsy.

Doi S, Adachi T, Watanabe A, Katsukura N, Tsujikawa T J Med Ultrason (2001). 2023; 51(2):235-243.

PMID: 38108995 DOI: 10.1007/s10396-023-01393-w.


Role of Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) in the Diagnosis of Suspicious Malignant Esophageal Strictures.

Min L, Qing Y, Chu Y, Liang C, Lv L, Liu D J Clin Med. 2023; 12(6).

PMID: 36983155 PMC: 10057162. DOI: 10.3390/jcm12062153.


Diagnosis and treatment of peritoneal carcinomatosis - a comprehensive overview.

Szadkowska M, Palucki J, Cieszanowski A Pol J Radiol. 2023; 88:e89-e97.

PMID: 36910885 PMC: 9995246. DOI: 10.5114/pjr.2023.125027.


Diagnostic and interventional EUS in hepatology: An updated review.

Jearth V, Sundaram S, Rana S Endosc Ultrasound. 2022; 11(5):355-370.

PMID: 36255023 PMC: 9688142. DOI: 10.4103/EUS-D-22-00027.


Role of therapeutic endoscopic ultrasound in gastrointestinal malignancy- current evidence and future directions.

Dhar J, Samanta J Clin J Gastroenterol. 2022; 15(1):11-29.

PMID: 35028906 DOI: 10.1007/s12328-021-01559-4.